It is estimated that 3.24 million new cancer cases and 1.66 million cancer deaths will be registered across Europe in 2024 and 40,800 of these deaths are from brain and central nervous system (CNS) cancers. Despite extensive efforts in molecular biology research, advances in biomedical engineering, artificial intelligence (AI) and big data science, brain tumours remain among the deadliest forms of cancer, resisting almost all conventional and novel treatments. To date, the behaviour of this devastating disease is not fully understood. To cure brain cancer, there are significant challenges in the early diagnosis, prognosis and patient stratification, drug development and drug resistance, and big data techniques. Addressing these challenges requires long-term continuous efforts and multidisciplinary collaboration.
This COST Action aims to significantly facilitate the translation of fundamental scientific discoveries into better clinical treatment and management of patients suffering from brain cancer. This aim will be pursued through the following main objectives: 1) to build a unique pan-European and multidisciplinary network focusing on brain cancer by combining state-of-the-art knowledge and innovative techniques; 2) to promote education and training in the areas of advanced neuroscience, neuroimaging, genetics and molecular biology, big data and computational techniques for the accurate early diagnosis, prognosis, patient stratification and treatment of patients with different types of brain cancer; and 3) to build an integrated pan-European brain cancer database and biobank platform for the benefit of the research and clinical community.
MoU - 013/23
CSO Approval date - 12/05/2023
Start date - 30/10/2023
End date - 29/10/2027
Action Chair: Prof. Xinzhong Li, Teesside University, Middlesbrough, United Kingdom
Grant Awarding Coordinator: Dr. Milica Pešić, Department of Neurobiology
Action members from IBISS:
Dr. Jelena Dinić, Department of Neurobiology
Dr. Sofija Jovanović Stojanov, Department of Neurobiology
Milica Pajović, Department of Neurobiology
Ema Lupšić, Department of Neurobiology
